MedPath

Find out the Visual outcome of Phakic Intraocular Lens for the correction of Nearsightedness

Phase 4
Conditions
Health Condition 1: null- High Myopic Patients
Registration Number
CTRI/2018/09/015651
Lead Sponsor
DR SIVAVIGANESH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Age >21 years

2. Stable refraction

3. Patients with myopia >-6.00D

4. Iridocorneal angle > 30 degree

5. Anterior chamber depth >2.7mm

6. Endothelial cell count > 2500 cells/sq.mm

7. Central corneal thickness >0.400 mm

Exclusion Criteria

1. Age <18 years

2. Unstable refraction

3. Hyperopia

4. AC depth <2.7mm.

5. Iridocorneal angle <30 degrees

6. Endothelial cell count <2500 cells /sq mm

7. Central corneal thickness <0.400 mm.

8. Any Lens Changes

9.Any Retinal degeneration which cause Impaired vision

10.Any Inflammatory Pathologies of Eye

11.Any Previous Ocular Surgeries

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Improvement in Best corrected visual acuity <br/ ><br>2.Anterior chamber depth <br/ ><br>3.Iridocorneal angle <br/ ><br>4.Endothelial count <br/ ><br>6.Central corneal thickness <br/ ><br>Timepoint: Post Op 1st Week 2nd Week 4th week 3rd Month and 6th Month
Secondary Outcome Measures
NameTimeMethod
1.Intra Ocular Pressure <br/ ><br>2.RIL Vaulting between Natural Lens and Phakic IOL <br/ ><br>3.Any Other Adverse EventsTimepoint: Post Op 1st Week 2nd Week 4th week 3rd Month and 6th Month
© Copyright 2025. All Rights Reserved by MedPath